Company News

The UK Intellectual Property Office granted 2nd of March 2016 the UK patent for Luer-Jack Lock. The patent is the frontrunner for similar filed applications (pending) in all important markets world wide and is a fundamental member of the Luer-Jack patent family, ensuring a very simple one-hand operated release of connections for different fluid transfer applications.

The Board of Directors of ConceptoMed AS announce the final completion of the successful private placement of equity in ConceptoMed AS for the period January-February 2016. The placement round was oversubscribed.

LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark)

FIRST ORDERS OF LUER-JACK SHIPPING AFTER CE-MARK APPROVAL

ConceptoMed today announced that the company has received CE Mark approval for the Luer-Jack® syringe, a new and innovative medical syringe. Luer-Jack® is now ready for the European market and other large markets, where the CE mark allows for market entry.

From June 2014 to July 2015, The Norwegian Research Council (VRI) supported an evaluation research study on Luer-Jack®, a new medical syringe with one-hand disconnection from needles/cannulas and luer type connections. The Intervention Centre of Oslo University Hospital has conducted the study, and the final report was submitted to ConceptoMed today, 1st of September 2015.

ConceptoMed is pleased to announce that it has reached a supply agreement with Becton, Dickinson & Company (BD) – a leading global medical technology company. ConceptoMed will use the different BD syringes in their production of Luer-Jack® – the new generation of medical syringes.

The Intellectual Property Office in the United Kingdom has granted approval for a second family of patents surrounding the Luer-Jack® technology. The patent was published on the 27th of May 2015 and is ConceptoMed’s third granted patent in a large and growing patent family.

​The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. Gross proceeds from the private placement amounts to NOK 9.5 Million (€1.05 Million).

On Monday 19th of January 2015, Runar Bjørklund, shareholder in ConceptoMed AS and former CFO of Nycomed, was appointed new Chairman of the Board.

The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. The share issue was oversubscribed and provided the company with 12 new shareholders. Gross proceeds from the private placement amounted to NOK 11,550,000 (€1.42 Million)

Luer-Jack™ is a unique medical syringe, which significantly increases control of the syringe and needles during disconnections. The Intellectual Property Office in the United Kingdom has granted approval for a UK Patent for fluid transfer devices (Luer-Jack™). The patent is ConceptoMed’s first granted patent and will be applied to other products in development.

The Board of ConceptoMed AS is pleased to announce the successful completion of a non-public offering. Gross proceeds from the Private Placement amount to NOK 5,005,000. The placement values the company at NOK 25 million. The process was opened at 18.00 CET Thursday 11 April 2013 and was completed at 15.00 CET Tuesday 16 April 2013. […]